# Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy

> **NCT00366080** · PHASE2 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 69 (actual)

## Conditions studied

- Narcolepsy

## Interventions

- **DRUG:** GSK189254

## Key facts

- **NCT ID:** NCT00366080
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** Study was terminated based on the interim results of a futility test.
- **Last updated:** 2017-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366080, "Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00366080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*